Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04308668 |
Recruitment Status :
Completed
First Posted : March 16, 2020
Last Update Posted : July 17, 2020
|
Sponsor:
University of Minnesota
Collaborators:
McGill University Health Centre/Research Institute of the McGill University Health Centre
University of Manitoba
University of Alberta
Information provided by (Responsible Party):
University of Minnesota
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | May 20, 2020 |
Actual Study Completion Date : | May 20, 2020 |
Publications of Results:
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):